Foamtec Medical: Optimized polyurethane foam swabs help reduce risk of false positive and negative COVID-19 results

Foamtec Medical is the only fully vertically integrated swab manufacturer that formulates and produces medical grade polyurethane foam
.
Foamtec Medical has developed a new foam formulation designed to capture maximum sample size and maximum release
.
This testing innovation provides extremely high recovery rates
.

"Consistent high volume collection of nasal or oral samples ensures that if there is an infection, it will be detected
," said Michael Strauss, general manager of Foamtec Medical.
"The high collection rate ensures that the maximum number of samples will be available for your test
.
If an infection is present in a patient, this volume recovery will help greatly reduce the risk of inaccurate test results
.
"

The U.
S.
Food and Drug Administration (FDA) issued a safety advisory on January 28, 2022, warning of the risk of misleading results for less accurate test brands
.
Foamtec Medical's optimized polyurethane foam swabs reduce the risk of unreliable results from viral and bacterial diagnostic tests
.

"Our R&D team has designed new foams for viral and bacterial diagnostics,
" Strauss said.
"No other foam swab manufacturer has come up with this requirement before us
.
"

R&D breakthroughs and advancements in testing technology at Foamtec Medical include:

● Has the traditional advantage of high sample capture volume of polyurethane foam
.

• Releases a higher percentage of sample than previous polyurethane foams
.

● Formulated with the only medical grade polyurethane foam on the market specifically for viral and bacterial diagnostics
.